There was no apparent increase in the levels of tumor markers, including carcinoembryonic antigen (CEA), carbohydrate antigen 19–9 (CA19-9), neuron-specific enolase (NSE), squamous cell carcinoma–related antigen (SCC), and interleukin-2 receptor. This evidence concerns the gene ENO2 and neoplasm.